Andere Sprachen Ventyx Biosciences, Inc.

Aktien

A3C53F

US92332V1070

VTYX

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 21.06.2024			% 5 Tage	% 1. Jan.
2,51 ^USD	0,00 %		-12,85 %	+1,62 %

11.06.	Transcript : Ventyx Biosciences, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-11-2024 08:40 AM
06.06.	VENTYX BIOSCIENCES, INC. : Oppenheimer behält seine Kaufempfehlung bei	ZM

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Ventyx Biosciences Preclinical Study of Obesity Control Candidate Shows Positive Results	05.06.
Ventyx Biosciences Announces Positive Preclinical Data for CNS-Penetrant NLRP3 Inhibitor VTX3232 Demonstrating Reversal of Obesity and Improvements in Cardiometabolic and Inflammatory Markers	05.06.
Ventyx Biosciences, Inc. Announces Positive Preclinical Data for CNS-Penetrant NLRP3 Inhibitor VTX3232 Demonstrating Reversal of Obesity and Improvements in Cardiometabolic and Inflammatory Markers	05.06.
Ventyx Biosciences to Participate in Three Upcoming Investor Conferences	16.05.
Ventyx Biosciences Appoints Matthew Moore as Chief Operating Officer; Shares Rise	16.05.
Ventyx Biosciences Announces Appointment of Matthew Moore as Chief Operating Officer	16.05.
Ventyx Biosciences Announces Appointment of Matthew Moore as Chief Operating Officer	16.05.
Ventyx Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09.05.
Ventyx Biosciences Reports First Quarter 2024 Financial Results and Highlights Recent Corporate Progress	09.05.
Ventyx Biosciences to Report First Quarter 2024 Financial Results on May 9, 2024	02.05.
VTYX DEADLINE TODAY: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Ventyx Biosciences, Inc. Investors to Secure Counsel Before Important April 30 Deadline in Securities Class Action - VTYX	30.04.
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Ventyx Biosciences, Inc. (VTYX)	29.04.
VTYX DEADLINE TOMORROW: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Ventyx Biosciences, Inc. Investors to Secure Counsel Before Important April 30 Deadline in Securities Class Action - VTYX	29.04.
Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ventyx Biosciences, Inc. of Class Action Lawsuit and Upcoming Deadlines - VTYX	28.04.
The Gross Law Firm Reminds Ventyx Biosciences, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 30, 2024 - VTYX	26.04.
VTYX DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Ventyx Biosciences, Inc. Investors to Secure Counsel Before Important April 30 Deadline in Securities Class Action - VTYX	26.04.
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ventyx Biosciences	25.04.
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Ventyx Biosciences, Inc. with Losses of $100,000 to Contact the Firm	24.04.
VTYX Investors Have Opportunity to Lead Ventyx Biosciences, Inc. Securities Fraud Lawsuit	23.04.
Levi & Korsinsky Notifies Shareholders of Ventyx Biosciences, Inc.(VTYX) of a Class Action Lawsuit and an Upcoming Deadline	22.04.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Ventyx Biosciences, Inc.

Aktien

A3C53F

US92332V1070

VTYX

Andere Sprachen

Filter